West Paces Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11
Closed -$381 – 737
2026
Q2
$381 Buy
+11
New +$295 ﹤0.01% 715
2022
Q3
– Sell
-50
Closed -$227 – 544
2022
Q2
$227 Hold
50
– – ﹤0.01% 569
2022
Q1
$267 Hold
50
– – ﹤0.01% 566
2021
Q4
$328 Buy
+50
New +$362 ﹤0.01% 565

Other funds holding HIMS

West Paces Advisors's HIMS Position: Q3 2026 in Review

West Paces Advisors sold out of Hims & Hers Health (HIMS) in Q3 2026, closing a stake of 11 shares — an estimated $381 sold.

West Paces Advisors first reported a position in HIMS in Q4 2021 and held it in 4 quarters. The position peaked at $381 in Q2 2026. 161 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • West Paces Advisors reported no remaining Hims & Hers Health position as of Q3 2026 after selling out during the quarter.
  • West Paces Advisors sold 11 Hims & Hers Health shares in Q3 2026, an estimated $381.
  • West Paces Advisors first reported a position in Hims & Hers Health in Q4 2021 and held it in 4 quarters.
  • West Paces Advisors's Hims & Hers Health position peaked at $381 in Q2 2026.
  • 161 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.